These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Physiopathologic observations on the treatment with antimetabolites in primary chronic polyarthritis and hepatitis]. Gerlach U Med Welt; 1967 Dec; 49():2982-5. PubMed ID: 5608854 [No Abstract] [Full Text] [Related]
28. [Medicamental immunosuppression in dermatology (author's transl)]. Goerz G; Merk H Z Hautkr; 1981 Aug; 56(15):975-90. PubMed ID: 7269720 [TBL] [Abstract][Full Text] [Related]
29. [Use of immuno-depressors in pediatrics]. Raybaud C Mars Med; 1967; 104(5):431-5. PubMed ID: 5608101 [No Abstract] [Full Text] [Related]
30. The use of chemotherapeutic agents in the treatment of non-neoplastic diseases. Barland P J Chronic Dis; 1971 May; 23(12):829-42. PubMed ID: 4934683 [No Abstract] [Full Text] [Related]
31. The management of collagen diseases. Calin A Ration Drug Ther; 1980 Jan; 14(1):1-5. PubMed ID: 7384531 [No Abstract] [Full Text] [Related]
35. [Current aspects on the teaching about so called collagen diseases (review of the literature)]. Isaeva LA; Kartasheva VI Vopr Okhr Materin Det; 1973 Nov; 18(11):57-61. PubMed ID: 4588527 [No Abstract] [Full Text] [Related]
36. [Current treatment of collagen diseases. 4. Immunosuppressive agents: key points in their application]. Auzuki A; Matsuoka Y Nihon Naika Gakkai Zasshi; 1997 Aug; 86(8):1409-13. PubMed ID: 9410946 [No Abstract] [Full Text] [Related]
38. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases]. Harigai M; Hara M; Kamatani N; Kashiwazaki S Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405 [TBL] [Abstract][Full Text] [Related]
39. [Symposium. I. Use of anti-allergic agents and their background]. Tsurufuji S; Mizushima Y; Kumagaya A; Yakura T; Morimoto Y Arerugi; 1971 Apr; 20(4):249-53. PubMed ID: 4324464 [No Abstract] [Full Text] [Related]